These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 7697732)

  • 81. CD73 is involved in lymphocyte binding to the endothelium: characterization of lymphocyte-vascular adhesion protein 2 identifies it as CD73.
    Airas L; Hellman J; Salmi M; Bono P; Puurunen T; Smith DJ; Jalkanen S
    J Exp Med; 1995 Nov; 182(5):1603-8. PubMed ID: 7595232
    [TBL] [Abstract][Full Text] [Related]  

  • 82. CD73 is expressed on invading T lymphocytes in the inflamed peripheral nerve.
    Meyer Zu Hörste G; Reiners J; Lehmann HC; Airas L; Kieseier BC
    Muscle Nerve; 2009 Aug; 40(2):287-9. PubMed ID: 19609917
    [TBL] [Abstract][Full Text] [Related]  

  • 83. CD73: a novel target for cancer immunotherapy.
    Zhang B
    Cancer Res; 2010 Aug; 70(16):6407-11. PubMed ID: 20682793
    [TBL] [Abstract][Full Text] [Related]  

  • 84. 5'-nucleotidase--an overview of the last three years.
    Thompson LF
    Adv Exp Med Biol; 1991; 309B():145-50. PubMed ID: 1781358
    [No Abstract]   [Full Text] [Related]  

  • 85. Ecto-5'-nucleotidase activity is not required for T cell activation through CD73.
    Gutensohn W; Resta R; Misumi Y; Ikehara Y; Thompson LF
    Cell Immunol; 1995 Apr; 161(2):213-7. PubMed ID: 7697732
    [TBL] [Abstract][Full Text] [Related]  

  • 86. CD73 (ecto-5'-nucleotidase) on blood mononuclear cells. Regulation of ecto-5'-nucleotidase activity and antigenic heterogeneity of CD73 on blood mononuclear cells from healthy donors and from patients with immunodeficiency.
    Christensen LD
    APMIS Suppl; 1997; 73():1-28. PubMed ID: 9393563
    [No Abstract]   [Full Text] [Related]  

  • 87. T cell signalling through CD73.
    Resta R; Thompson LF
    Cell Signal; 1997 Feb; 9(2):131-9. PubMed ID: 9113412
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Amplification of T cell activation induced by CD73 (ecto-5' nucleotidase) engagement.
    Massaia M; Attisano C; Redoglia V; Bianchi A; Thompson LF; Dianzani U; Pileri A
    Adv Exp Med Biol; 1991; 309B():155-8. PubMed ID: 1838231
    [No Abstract]   [Full Text] [Related]  

  • 89. Ecto-enzyme and signaling functions of lymphocyte CD73.
    Resta R; Yamashita Y; Thompson LF
    Immunol Rev; 1998 Feb; 161():95-109. PubMed ID: 9553767
    [TBL] [Abstract][Full Text] [Related]  

  • 90. CD73: a potent suppressor of antitumor immune responses.
    Beavis PA; Stagg J; Darcy PK; Smyth MJ
    Trends Immunol; 2012 May; 33(5):231-7. PubMed ID: 22487321
    [TBL] [Abstract][Full Text] [Related]  

  • 91.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 92.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 93.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 94.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 95.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 5.